Pharma Latch
Pharma Latch has revolutionized intradermal drug delivery with innovative microneedle technology, enabling simple, reliable, and repeatable intradermal injections for a wide range of therapies. Their platform supports the entire R&D process, from pre-clinical testing to clinical and self-administration devices, aiming to unlock the full therapeutic potential of intradermal drug delivery.
Industries
Nr. of Employees
small (1-50)
Pharma Latch
Products
Healthcare-professional-administered sterile single-use hollow intradermal device
A hollow microneedle intradermal device designed for HCP administration; described as sterile and single-use and listed as on an FDA 510(k) regulatory pathway in the U.S.
Preclinical small-animal intradermal research device
A research tool engineered for intradermal dosing in small animals (mice/rats) to ensure accurate, consistent and complete dermal dose delivery; compatible with Luer Lock/Slip syringes.
Patient self-administration intradermal device
A self-injection device integrating the intradermal microneedle platform to enable patient-friendly home administration while maintaining precision.
Healthcare-professional-administered sterile single-use hollow intradermal device
A hollow microneedle intradermal device designed for HCP administration; described as sterile and single-use and listed as on an FDA 510(k) regulatory pathway in the U.S.
Preclinical small-animal intradermal research device
A research tool engineered for intradermal dosing in small animals (mice/rats) to ensure accurate, consistent and complete dermal dose delivery; compatible with Luer Lock/Slip syringes.
Patient self-administration intradermal device
A self-injection device integrating the intradermal microneedle platform to enable patient-friendly home administration while maintaining precision.
Services
R&D partnership and device customization
Collaborative support across preclinical, clinical and commercial stages to adapt intradermal delivery devices to program needs.
Manufacturing scale-up via certified contract facilities
Manufacturing line established at FDA and ISO certified partner facilities to support commercial production of intradermal devices.
Technical pack provision
Provision of technical documentation and specifications to support external evaluation and integration of the intradermal platform.
R&D partnership and device customization
Collaborative support across preclinical, clinical and commercial stages to adapt intradermal delivery devices to program needs.
Manufacturing scale-up via certified contract facilities
Manufacturing line established at FDA and ISO certified partner facilities to support commercial production of intradermal devices.
Technical pack provision
Provision of technical documentation and specifications to support external evaluation and integration of the intradermal platform.
Expertise Areas
- Intradermal drug delivery
- Microneedle device engineering
- Preclinical intradermal testing
- Vaccine and mRNA delivery
Key Technologies
- Intradermal microneedle arrays (opposing-angled)
- Device geometry-controlled insertion depth
- Multi-needle fluid distribution
- Low-dead-volume fluidic design